176 related articles for article (PubMed ID: 26087260)
1. The economic burden of cancer in the UK: a study of survivors treated with curative intent.
Marti J; Hall PS; Hamilton P; Hulme CT; Jones H; Velikova G; Ashley L; Wright P
Psychooncology; 2016 Jan; 25(1):77-83. PubMed ID: 26087260
[TBL] [Abstract][Full Text] [Related]
2. Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data.
Hall PS; Hamilton P; Hulme CT; Meads DM; Jones H; Newsham A; Marti J; Smith AF; Mason H; Velikova G; Ashley L; Wright P
Br J Cancer; 2015 Mar; 112(5):948-56. PubMed ID: 25602964
[TBL] [Abstract][Full Text] [Related]
3. How much does it cost to care for survivors of colorectal cancer? Caregiver's time, travel and out-of-pocket costs.
Hanly P; Céilleachair AÓ; Skally M; O'Leary E; Kapur K; Fitzpatrick P; Staines A; Sharp L
Support Care Cancer; 2013 Sep; 21(9):2583-92. PubMed ID: 23649879
[TBL] [Abstract][Full Text] [Related]
4. Estimating the cost of caring for people with cancer at the end of life: A modelling study.
Round J; Jones L; Morris S
Palliat Med; 2015 Dec; 29(10):899-907. PubMed ID: 26199134
[TBL] [Abstract][Full Text] [Related]
5. The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients.
Koskinen JP; Färkkilä N; Sintonen H; Saarto T; Taari K; Roine RP
Acta Oncol; 2019 Jul; 58(7):1062-1068. PubMed ID: 30943813
[No Abstract] [Full Text] [Related]
6. Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario, Canada.
de Oliveira C; Bremner KE; Ni A; Alibhai SM; Laporte A; Krahn MD
J Cancer Surviv; 2014 Mar; 8(1):9-20. PubMed ID: 23975612
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of trends in the cost of initial cancer treatment.
Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
[TBL] [Abstract][Full Text] [Related]
8. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
McGarvey N; Gitlin M; Fadli E; Chung KC
J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
[TBL] [Abstract][Full Text] [Related]
9. Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.
Zheng Z; Yabroff KR; Guy GP; Han X; Li C; Banegas MP; Ekwueme DU; Jemal A
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26705361
[TBL] [Abstract][Full Text] [Related]
10. Out-of-pocket costs and burden among rural breast cancer survivors.
Pisu M; Azuero A; Benz R; McNees P; Meneses K
Cancer Med; 2017 Mar; 6(3):572-581. PubMed ID: 28229562
[TBL] [Abstract][Full Text] [Related]
11. Financial and family burden associated with cancer treatment in Ontario, Canada.
Longo CJ; Fitch M; Deber RB; Williams AP
Support Care Cancer; 2006 Nov; 14(11):1077-85. PubMed ID: 16896878
[TBL] [Abstract][Full Text] [Related]
12. Out-of-pocket medical expenses compared across five years for patients with one of five common cancers in Australia.
Rodriguez-Acevedo AJ; Chan RJ; Olsen CM; Pandeya N; Whiteman DC; Gordon LG
BMC Cancer; 2021 Sep; 21(1):1055. PubMed ID: 34563142
[TBL] [Abstract][Full Text] [Related]
13. The Economic Burden of Breast Cancer Survivors in Korea: A Descriptive Study Using a 26-Month Micro-Costing Cohort Approach.
You CH; Kang S; Kwon YD
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2131-2137. PubMed ID: 31350976
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the ventricular assist device programme in the UK.
Sharples L; Buxton M; Caine N; Cafferty F; Demiris N; Dyer M; Freeman C
Health Technol Assess; 2006 Nov; 10(48):1-119, iii-iv. PubMed ID: 17134596
[TBL] [Abstract][Full Text] [Related]
15. Sarcoma epidemiology and cancer-related hospitalisation in Western Australia from 1982 to 2016: a descriptive study using linked administrative data.
Wright CM; Halkett G; Carey Smith R; Moorin R
BMC Cancer; 2020 Jul; 20(1):625. PubMed ID: 32631311
[TBL] [Abstract][Full Text] [Related]
16. Estimating time and out-of-pocket costs incurred by families attending a pediatric cochlear implant programme.
Sach TH; Whynes DK; Archbold SM; O'Donoghue GM
Int J Pediatr Otorhinolaryngol; 2005 Jul; 69(7):929-36. PubMed ID: 15911011
[TBL] [Abstract][Full Text] [Related]
17. The Economic Burden of Breast Cancer in Korea from 2007-2010.
Kim YA; Oh IH; Yoon SJ; Kim HJ; Seo HY; Kim EJ; Lee YH; Jung JH
Cancer Res Treat; 2015 Oct; 47(4):583-90. PubMed ID: 25687860
[TBL] [Abstract][Full Text] [Related]
18. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
[TBL] [Abstract][Full Text] [Related]
19. The economic value of primary prophylaxis using pegfilgrastim compared with filgrastim in patients with breast cancer in the UK.
Liu Z; Doan QV; Malin J; Leonard R
Appl Health Econ Health Policy; 2009; 7(3):193-205. PubMed ID: 19799473
[TBL] [Abstract][Full Text] [Related]
20. The economic burden of prostate cancer - a Swedish prevalence-based register study.
Hao S; Östensson E; Eklund M; Grönberg H; Nordström T; Heintz E; Clements M
BMC Health Serv Res; 2020 May; 20(1):448. PubMed ID: 32434566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
